Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06563388
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Who this might be right for
OligometastasisLung CancerColo-rectal Cancer+1 more
Roswell Park Cancer Institute 800
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 542
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Ended earlyNCT00041691
What this trial is testing

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

Who this might be right for
Colorectal Neoplasms
Gilead Sciences 30
Not applicableLooking for participantsNCT06568016
What this trial is testing

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

Who this might be right for
Colorectal Carcinoma
Jonsson Comprehensive Cancer Center 1,500
Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Not applicableStudy completedNCT00836992
What this trial is testing

Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+8 more
Mayo Clinic 144
Not applicableNot Yet RecruitingNCT07497789
What this trial is testing

SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases

Who this might be right for
CRC (Colorectal Cancer)Liver Metastases From Colorectal Primary Cancer
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 156
Not applicableStudy completedNCT00955188
What this trial is testing

Computer-Based Tailored or Standard Information for Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
University of Michigan Rogel Cancer Center 345
Testing effectiveness (Phase 2)Study completedNCT00004005
What this trial is testing

Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

Who this might be right for
Carcinoma of Unknown PrimaryColorectal CancerUnspecified Adult Solid Tumor, Protocol Specific+1 more
St. Jude Children's Research Hospital 12
Not applicableStudy completedNCT01026753
What this trial is testing

Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

Who this might be right for
Colorectal Cancer
University of Manitoba 2,395
Not applicableLooking for participantsNCT02906943
What this trial is testing

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Who this might be right for
Breast CancerLung CancerColorectal Cancer+8 more
University Health Network, Toronto 10,000
Not applicableLooking for participantsNCT07617610
What this trial is testing

Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerBRAF V600E Mutation
Swiss Cancer Institute 30
Not applicableStudy completedNCT01651624
What this trial is testing

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District

Who this might be right for
Colorectal Cancer
Cancer Prevention and Research Institute, Italy 16,087
Not applicableActive Not RecruitingNCT04745754
What this trial is testing

The Engaging Primary Care in Cancer Survivorship (EPICS) Study

Who this might be right for
Breast CancerColorectal Cancer
Kaiser Permanente 2,450
Large-scale testing (Phase 3)Active Not RecruitingNCT03635021
What this trial is testing

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 419
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Large-scale testing (Phase 3)Active Not RecruitingNCT01558921
What this trial is testing

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

Who this might be right for
Rectal Cancer
University Medical Center Groningen 920
Testing effectiveness (Phase 2)WithdrawnNCT06410534
What this trial is testing

A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer

Who this might be right for
Colorectal CancerGastroesophageal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Next Page